Heights Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Other funds holding PHIO
Heights Capital Management's PHIO Position: Q2 2020 in Review
Heights Capital Management sold out of Phio Pharmaceuticals (PHIO) in Q2 2020, closing a stake of 3,334 shares — an estimated $637K sold.
Heights Capital Management first reported a position in PHIO in Q4 2018 and held it in 5 quarters. The position peaked at $637K in Q1 2020. 6 funds tracked by Wall St. Rank hold PHIO as of Q2 2020.
- Heights Capital Management reported no remaining Phio Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Heights Capital Management sold 3,334 Phio Pharmaceuticals shares in Q2 2020, an estimated $637K.
- Heights Capital Management first reported a position in Phio Pharmaceuticals in Q4 2018 and held it in 5 quarters.
- Heights Capital Management's Phio Pharmaceuticals position peaked at $637K in Q1 2020.
- 6 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2020.
Based on Heights Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.